Larvol Delta - Alzamend-Neuro-Submits-IND-Application-for-a-Phase-IIA-Clinical-Trial-in-Major-Depressive-Disorder-Patients-of-its-NextGeneration-Lithium-Therapeutic-Drug-Candidate-AL001

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20231023303175/en/Alzamend-Neuro-Submits-IND-Application-for-a-Phase-IIA-Clinical-Trial-in-Major-Depressive-Disorder-Patients-of-its-Next%E2%80%91Generation-Lithium-Therapeutic-Drug-Candidate-AL001

Oct 23, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next